Name: CYTOSORBENTS CORP (CTSO) Stock
Brand: CYTOSORBENTS CORP
Rating: 3.5 (3 reviews)

CTSO Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: Cytosorbents Corp

CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights

a month ago - By: Cytosorbents Corp

CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen

2 months ago - By: Benzinga

Deep Dive Into CytoSorbents Stock: Analyst Perspectives (5 Ratings)

2 months ago - By: Cytosorbents Corp

CytoSorbents Provides DrugSorb-ATR Regulatory Update

2 months ago - By: Cytosorbents Corp

CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day

2 months ago - By: Cytosorbents Corp

CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference

3 months ago - By: Benzinga

Demystifying CytoSorbents: Insights From 5 Analyst Reviews

2 months ago - By: CytoSorbents Corporation

CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR

3 months ago - By: Cytosorbents Corp

CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update

3 months ago - By: Cytosorbents Corp

CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights

4 months ago - By: Cytosorbents Corp

CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR

4 months ago - By: Cytosorbents Corp

CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR

5 months ago - By: Cytosorbents Corp

CytoSorbents to Participate at the Jefferies Global Healthcare Conference

5 months ago - By: Cytosorbents Corp

CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025

6 months ago - By: Cytosorbents Corp

CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update

6 months ago - By: Cytosorbents Corp

CytoSorbents Provides Regulatory Update for DrugSorb-ATR

6 months ago - By: Cytosorbents Corp

CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights

6 months ago - By: CytoSorbents Corporation

CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program

7 months ago - By: Cytosorbents Corp

CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller

7 months ago - By: Cytosorbents Corp

CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America

7 months ago - By: Cytosorbents Corp

CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants

7 months ago - By: Cytosorbents Corp

CYTOSORBENTS CORP (CTSO) Stock News

CTSO Latest News, Press Relases and Analysis

CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights

CytoSorbents to Showcase Pioneering New Cardiac Surgery Data in Key Applications at the EACTS 2025 Annual Meeting in Copenhagen

Deep Dive Into CytoSorbents Stock: Analyst Perspectives (5 Ratings)

CytoSorbents Provides DrugSorb-ATR Regulatory Update

CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day

CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Demystifying CytoSorbents: Insights From 5 Analyst Reviews

CytoSorbents Updates U.S. FDA Regulatory Status of DrugSorb-ATR

CytoSorbents Reports Second Quarter 2025 Financial Results and Provides Business Update

CytoSorbents to Report Second Quarter 2025 Financial Results and Recent Business Highlights

CytoSorbents Provides U.S. FDA and Health Canada Regulatory Update for DrugSorb-ATR

CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR

CytoSorbents to Participate at the Jefferies Global Healthcare Conference

CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025

CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update

CytoSorbents Provides Regulatory Update for DrugSorb-ATR

CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights

CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program

CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller

CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America

CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants

CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights